New President of FreseniusRx to Build on Company’s Success in Contributing to Positive Patient Outcomes
April 13 2017 - 8:36AM
Business Wire
RJ Correia takes the helm as FreseniusRx’s
pharmacy customers experience improved health measurements
FreseniusRx, a nationwide pharmacy focused on medication access
and adherence for patients on dialysis, announced today that it has
named Randell (RJ) Correia, PharmD, as its new President. In this
role, Correia will oversee the planning and execution of
FreseniusRx’s growth strategies at a time when the business and its
parent organization, Fresenius Medical Care North America (FMCNA),
are actively transitioning to value-based care and achieving
demonstrated success in improving patient health and reducing costs
to the health care system.
Correia joins FreseniusRx after most recently serving as a
consultant for KNR Enterprises, LLC, a company he founded, which
advises organizations on managed care and the specialty pharmacy
business. He additionally served as President and COO of US Script,
Centene Corporation’s pharmacy benefit manager (PBM), and prior to
that led OptumRx, a UnitedHealth Group company, where he oversaw
the growth of pharmacy services. Correia received his Doctor of
Pharmacy from the University of the Pacific in Stockton,
California.
“We are thrilled that RJ has agreed to lead FreseniusRx and is
bringing his talents, industry insights and patients-first mindset
to the organization,” said William McKinney, President of FMCNA’s
Integrated Care Group. “FreseniusRx is a significant contributor to
Fresenius Medical Care’s focus on value-based delivery of care, and
RJ’s leadership of our high-performing pharmacy team will help
build upon our success.”
“I am proud to lead the FreseniusRx team in working as an
integrated partner with FMCNA’s clinic staff to help improve
patients’ access and adherence to the renal medications they need,”
said Correia. “This coordinated approach to care is yielding
important and exciting results for our customers and the health
care system at large, and our entire pharmacy team is excited to
advance these accomplishments further.”
Recent data on FreseniusRx’s patient care impact indicates that
within their first nine months of enrollment, dialysis patients who
use FreseniusRx’s services experienced a 9 percent improvement in
their target ranges for blood calcium, phosphorus and intact
parathyroid hormone goals, compared to patients who were not using
FreseniusRx.
FreseniusRx is the only pharmacy in the nation to have partnered
on a specialized education curriculum for pharmacists with the
National Kidney Foundation and the Albany College of Pharmacy and
Health Sciences. It offers convenient medication delivery options,
and its pharmacists are available to speak with patients 24 hours a
day, seven days a week.
About FreseniusRx
Headquartered in Franklin, Tennessee, FreseniusRx provides
specialized medication management and pharmaceutical services to
chronic kidney disease patients across the country. FreseniusRx
works with care teams to understand every patient’s unique needs
and supports patients and their caregivers through the challenges
of kidney disease. As a part of the Fresenius Medical Care family,
FreseniusRx provides physicians with access to unique insights and
patient data to help drive strong outcomes and improve quality of
care and patient satisfaction.
About Fresenius Medical Care North
America
Fresenius Medical Care North America is the premier health care
company focused on providing the highest quality care to people
with renal and other chronic conditions. Through its
industry-leading network of dialysis facilities, outpatient cardiac
and vascular labs, and urgent care centers, as well as the
country’s largest practice of hospitalist and post-acute providers,
Fresenius Medical Care provides coordinated health care services at
pivotal care points for hundreds of thousands of chronically ill
customers throughout the continent. As the world’s largest fully
vertically integrated renal company, it offers specialty pharmacy
and laboratory services, and manufactures and distributes the most
comprehensive line of dialysis equipment, disposable products, and
renal pharmaceuticals. For more information, visit the FMCNA
website at www.fmcna.com
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170413005636/en/
Fresenius Medical Care North AmericaJon Stone,
781-392-4680Jonathan.d.stone@fmc-na.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2023 to Apr 2024